PolyPeptide Group AG (PPGN.SW)

CHF 29.65

(2.24%)

EBITDA Summary of PolyPeptide Group AG

  • PolyPeptide Group AG's latest annual EBITDA in 2023 was -12.3 Million EUR , down -167.02% from previous year.
  • PolyPeptide Group AG's latest quarterly EBITDA in 2023 FY was N/A , down -167.02% from previous quarter.
  • PolyPeptide Group AG reported an annual EBITDA of 35.72 Million EUR in 2022, down -60.39% from previous year.
  • PolyPeptide Group AG reported an annual EBITDA of 83.35 Million EUR in 2021, up 42.81% from previous year.
  • PolyPeptide Group AG reported a quarterly EBITDA of -2.42 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • PolyPeptide Group AG reported a quarterly EBITDA of N/A for 2023 FY, down -167.02% from previous quarter.

Annual EBITDA Chart of PolyPeptide Group AG (2023 - 2018)

Historical Annual EBITDA of PolyPeptide Group AG (2023 - 2018)

Year EBITDA EBITDA Growth
2023 -12.3 Million EUR -167.02%
2022 35.72 Million EUR -60.39%
2021 83.35 Million EUR 42.81%
2020 58.54 Million EUR 18.29%
2019 49.28 Million EUR 16.01%
2018 42.58 Million EUR 0.0%

Peer EBITDA Comparison of PolyPeptide Group AG

Name EBITDA EBITDA Difference
Siegfried Holding AG 241.21 Million CHF 105.103%